{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:14:00Z","timestamp":1783527240205,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40615-025-02497-4","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:50:35Z","timestamp":1748346635000},"page":"3265-3273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Active Surveillance for Prostate Cancer in \u201cReal-World\u201d Setting: Exploring Racial Disparities"],"prefix":"10.1007","volume":"13","author":[{"given":"Alessio","family":"Finocchiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Vigan\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cusmano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Guivatchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Dinesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sorce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"1","key":"2497_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA A Cancer J Clinicians. 2023;73(1):17\u201348.","journal-title":"CA A Cancer J Clinicians"},{"key":"2497_CR2","doi-asserted-by":"crossref","unstructured":"Frey T. Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. AMWA [Internet]. 2023 Mar 2 [cited 2025 May 13];38(1). Available from: https:\/\/amwajournal.org\/index.php\/amwa\/article\/view\/195","DOI":"10.55752\/amwa.2023.195"},{"key":"2497_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canep.2016.07.019","volume":"44","author":"MR Benjamins","year":"2016","unstructured":"Benjamins MR, Hunt BR, Raleigh SM, Hirschtick JL, Hughes MM. Racial disparities in prostate cancer mortality in the 50 largest US cities. Cancer Epidemiol. 2016;44:125\u201331.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"2497_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2016.20324","volume":"317","author":"AH Mokdad","year":"2017","unstructured":"Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, et al. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980\u20132014. JAMA. 2017;317(4):388.","journal-title":"JAMA"},{"issue":"3","key":"2497_CR5","doi-asserted-by":"publisher","first-page":"e201839","DOI":"10.1001\/jamanetworkopen.2020.1839","volume":"3","author":"SA Fletcher","year":"2020","unstructured":"Fletcher SA, Marchese M, Cole AP, Mahal BA, Friedlander DF, Krimphove M, et al. Geographic Distribution of Racial Differences in Prostate Cancer Mortality. JAMA Netw Open. 2020;3(3):e201839.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2497_CR6","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/pros.20449","volume":"66","author":"JC Schroeder","year":"2006","unstructured":"Schroeder JC, Bensen JT, Su LJ, Mishel M, Ivanova A, Smith GJ, et al. The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate. 2006;66(11):1162\u201376.","journal-title":"Prostate"},{"issue":"1","key":"2497_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2015.6036","volume":"314","author":"MR Cooperberg","year":"2015","unstructured":"Cooperberg MR, Carroll PR. Trends in Management for Patients With Localized Prostate Cancer, 1990\u20132013. JAMA. 2015;314(1):80.","journal-title":"JAMA"},{"issue":"17","key":"2497_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547\u201358.","journal-title":"N Engl J Med"},{"issue":"6","key":"2497_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","volume":"77","author":"JJ Tosoian","year":"2020","unstructured":"Tosoian JJ, Mamawala M, Epstein JI, Landis P, Macura KJ, Simopoulos DN, et al. Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort. Eur Urol. 2020;77(6):675\u201382.","journal-title":"Eur Urol"},{"issue":"3","key":"2497_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. JCO. 2015;33(3):272\u20137.","journal-title":"JCO"},{"issue":"7","key":"2497_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.2018.19941","volume":"321","author":"BA Mahal","year":"2019","unstructured":"Mahal BA, Butler S, Franco I, Spratt DE, Rebbeck TR, D\u2019Amico AV, et al. Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010\u20132015. JAMA. 2019;321(7):704.","journal-title":"JAMA"},{"issue":"2","key":"2497_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.urology.2013.09.038","volume":"83","author":"BD Odom","year":"2014","unstructured":"Odom BD, Mir MC, Hughes S, Senechal C, Santy A, Eyraud R, et al. Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience. Urology. 2014;83(2):364\u20138.","journal-title":"Urology"},{"issue":"5","key":"2497_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.juro.2011.12.082","volume":"187","author":"V Iremashvili","year":"2012","unstructured":"Iremashvili V, Soloway MS, Rosenberg DL, Manoharan M. Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. J Urol. 2012;187(5):1594\u2013600.","journal-title":"J Urol"},{"issue":"1","key":"2497_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/pcan.2012.38","volume":"16","author":"MR Abern","year":"2013","unstructured":"Abern MR, Bassett MR, Tsivian M, Ba\u00f1ez LL, Polascik TJ, Ferrandino MN, et al. Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center. Prostate Cancer Prostatic Dis. 2013;16(1):85\u201390.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2497_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.urology.2014.08.014","volume":"85","author":"D Sundi","year":"2015","unstructured":"Sundi D, Faisal FA, Trock BJ, Landis PK, Feng Z, Ross AE, et al. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology. 2015;85(1):155\u201360.","journal-title":"Urology"},{"issue":"1","key":"2497_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bju.13193","volume":"118","author":"JW Davis","year":"2016","unstructured":"Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, et al. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016;118(1):68\u201376.","journal-title":"BJU Int"},{"key":"2497_CR17","unstructured":"EAU PCa Guidelines."},{"issue":"1","key":"2497_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/JU.0000000000002758","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, Chou R, Crispino T, Davis JW, et al. Clinically localized prostate cancer: AUA\/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up. J Urol. 2022;208(1):19\u201325.","journal-title":"J Urol"},{"issue":"12","key":"2497_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/cncr.30687","volume":"123","author":"A Tsodikov","year":"2017","unstructured":"Tsodikov A, Gulati R, De Carvalho TM, Heijnsdijk EAM, Hunter-Merrill RA, Mariotto AB, et al. Is prostate cancer different in black men? Answers from 3 natural history models. Cancer. 2017;123(12):2312\u20139.","journal-title":"Cancer"},{"issue":"3","key":"2497_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.urology.2009.10.061","volume":"76","author":"CD Mullins","year":"2010","unstructured":"Mullins CD, Onukwugha E, Bikov K, Seal B, Hussain A. Health disparities in staging of SEER-medicare prostate cancer patients in the United States. Urology. 2010;76(3):566\u201372.","journal-title":"Urology"},{"issue":"14","key":"2497_CR21","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/cncr.32930","volume":"126","author":"AB Weiner","year":"2020","unstructured":"Weiner AB, Vo AX, Desai AS, Hu JC, Spratt DE, Schaeffer EM. Changes in prostate-specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men. Cancer. 2020;126(14):3229\u201336.","journal-title":"Cancer"},{"issue":"10","key":"2497_CR22","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/cncr.31932","volume":"125","author":"BE Gordon","year":"2019","unstructured":"Gordon BE, Basak R, Carpenter WR, Usinger D, Godley PA, Chen RC. Factors influencing prostate cancer treatment decisions for African American and white men. Cancer. 2019;125(10):1693\u2013700.","journal-title":"Cancer"},{"issue":"4","key":"2497_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2022.03.007","volume":"82","author":"YA Nyame","year":"2022","unstructured":"Nyame YA, Cooperberg MR, Cumberbatch MG, Eggener SE, Etzioni R, Gomez SL, et al. Deconstructing, addressing, and eliminating racial and ethnic inequities in prostate cancer care. Eur Urol. 2022;82(4):341\u201351.","journal-title":"Eur Urol"},{"issue":"7","key":"2497_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","volume":"5","author":"RT Dess","year":"2019","unstructured":"Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5(7):975.","journal-title":"JAMA Oncol"},{"issue":"17","key":"2497_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1001\/jama.2020.17020","volume":"324","author":"R Deka","year":"2020","unstructured":"Deka R, Courtney PT, Parsons JK, Nelson TJ, Nalawade V, Luterstein E, et al. Association between african american race and clinical outcomes in men treated for low-risk prostate cancer with active surveillance. JAMA. 2020;324(17):1747.","journal-title":"JAMA"},{"key":"2497_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.urology.2020.09.044","volume":"148","author":"JW Greenberg","year":"2021","unstructured":"Greenberg JW, Leinwand G, Feibus AH, Haney NM, Krane LS, Thomas R, et al. Prospective observational study of a racially diverse group of men on active surveillance for prostate cancer. Urology. 2021;148:203\u201310.","journal-title":"Urology"},{"issue":"3","key":"2497_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/pcan.2011.18","volume":"14","author":"HS Kim","year":"2011","unstructured":"Kim HS, Moreira DM, Jayachandran J, Gerber L, Ba\u00f1ez LL, Vollmer RT, et al. Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis. 2011;14(3):262\u20135.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"2497_CR28","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1097\/01.ju.0000127739.88383.79","volume":"171","author":"JL Mohler","year":"2004","unstructured":"Mohler JL, Gaston KE, Moore DT, Schell MJ, Cohen BL, Weaver C, et al. Racial differences in prostate androgen levels in men with clinically localized prostate cancer. J Urol. 2004;171(6):2277\u201380.","journal-title":"J Urol"},{"issue":"3","key":"2497_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11523-020-00721-1","volume":"15","author":"E Raymond","year":"2020","unstructured":"Raymond E, Thieblemont C, Alran S, Faivre S. Impact of the COVID-19 outbreak on the management of patients with cancer. Targ Oncol. 2020;15(3):249\u201359.","journal-title":"Targ Oncol"},{"issue":"8","key":"2497_CR30","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.annonc.2020.05.009","volume":"31","author":"A Sud","year":"2020","unstructured":"Sud A, Jones ME, Broggio J, Loveday C, Torr B, Garrett A, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020;31(8):1065\u201374.","journal-title":"Ann Oncol"},{"key":"2497_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","volume":"67","author":"T Li","year":"2023","unstructured":"Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, et al. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis. The Breast. 2023;67:78\u201388.","journal-title":"The Breast"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02497-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:20:00Z","timestamp":1783524000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02497-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2497"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02497-4","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were retrospectively enrolled in HFH-IRB#12641\u201329. In accordance with institutional regulations for de-identified previously collected data, an institutional review board waiver for informed consent was obtained before conducting this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"None of the authors have any relevant disclosures, and none have any financial or non-financial interests pertinent to the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}